Abstract
Bentham Science Publishers would like to thank and appreciate the co-operation from all contributors for high quality contributions submitted to Recent Patents on Inflammation & Allergy Drug Discovery. Their efforts have contributed greatly to the high quality and continuous growth of the journal. Given below is the list of contributors who submitted their articles received for the Journal during 2011-2012:.....
Recent Patents on Inflammation & Allergy Drug Discovery
Title:Acknowledgment to Contributors
Volume: 6 Issue: 3
Author(s): Bentham Science Publishers
Affiliation:
Abstract: Bentham Science Publishers would like to thank and appreciate the co-operation from all contributors for high quality contributions submitted to Recent Patents on Inflammation & Allergy Drug Discovery. Their efforts have contributed greatly to the high quality and continuous growth of the journal. Given below is the list of contributors who submitted their articles received for the Journal during 2011-2012:.....
Export Options
About this article
Cite this article as:
Science Publishers Bentham, Acknowledgment to Contributors, Recent Patents on Inflammation & Allergy Drug Discovery 2012; 6 (3) . https://dx.doi.org/10.2174/187221312802652811
DOI https://dx.doi.org/10.2174/187221312802652811 |
Print ISSN 1872-213X |
Publisher Name Bentham Science Publisher |
Online ISSN 2212-2710 |
Related Articles
-
Mediterranean Diet and Low-grade Subclinical Inflammation: The Moli-sani Study
Endocrine, Metabolic & Immune Disorders - Drug Targets Editorial [Hot Topic: Ion Channels as Therapeutic Targets for Neuropathic Pain (Executive Editor: Char-Chang Shieh)]
Current Pharmaceutical Design Expression Suppression and Activity Inhibition of TRPM7 Regulate Cytokine Production and Multiple Organ Dysfunction Syndrome During Endotoxemia: a New Target for Sepsis
Current Molecular Medicine Host Defense Peptides and the New Line of Defence Against Multiresistant Infections
Protein & Peptide Letters Endothelium as a Therapeutic Target in Diabetes Mellitus: From Basic Mechanisms to Clinical Practice
Current Medicinal Chemistry The Second Generation of COX-2 Inhibitors: Clinical Pharmacological Point of View
Mini-Reviews in Medicinal Chemistry Gamma Linolenic Acid: An Antiinflammatory Omega-6 Fatty Acid
Current Pharmaceutical Biotechnology IL-1 as a target in inflammation
Endocrine, Metabolic & Immune Disorders - Drug Targets Inflammasome Signaling and Other Factors Implicated in Atherosclerosis Development and Progression
Current Pharmaceutical Design Pathophysiology and Management of Atopic Dermatitis: A Laconic Review
Current Drug Therapy Does Inhaled Corticosteroid Treatment Result in a Secondary Immune Deficiency Predisposing To Recurrent Infections?
Anti-Inflammatory & Anti-Allergy Agents in Medicinal Chemistry Anti-Infective and Anti-Tumor Agents Based on the Depletion of Immune Suppressive Effects
Current Medicinal Chemistry A Review of Select Recent Patents on Novel Nanocarriers
Recent Patents on Drug Delivery & Formulation “Endothelial Progenitor Cells” as a Therapeutic Strategy in Cardiovascular Disease
Current Vascular Pharmacology Selenium in the Therapy of Neurological Diseases. Where is it Going?
Current Neuropharmacology Therapeutic Approach of Primary Bone Tumours by Bisphosphonates
Current Pharmaceutical Design Mesenchymal Stem Cells: Promising for Myocardial Regeneration?
Current Stem Cell Research & Therapy TNF-α Induction by Nickel Compounds is Specific Through ERKs/AP-1- Dependent Pathway in Human Bronchial Epithelial Cells
Current Cancer Drug Targets Protective Effects of Pituitary Adenylate Cyclase-Activating Polypeptide (PACAP) Against Apoptosis
Current Pharmaceutical Design Does the Septic Shock Interfere Experimental Acute Pancreatitis in Rats?
Medicinal Chemistry